1.
Werth V, Joly P, Mimouni D, Maverakis E, Lahane P, Gearhart L, Pordeli P, Chen D. A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris. J of Skin [Internet]. 2020 Jan. 28 [cited 2024 Jul. 3];4(1):S26. Available from: https://jofskin.org/33014/index.php/skin/article/view/806